Comparative efficacy and safety of colistin-based and alternative antibiotic regimens for multidrug-resistant Gram-negative infections: A systematic review and network meta-analysis
Abstract
OBJECTIVES: To evaluate the comparative efficacy and safety of colistin monotherapy, colistin-based combination regimens, and alternative antibiotic strategies within a unified analytical framework for multidrug-resistant (MDR) Gram-negative infections. METHODS: Systematic search of PubMed, the Cochrane Library, Embase, and Web of Science was conducted from inception to July 15, 2025. A network meta-analysis integrating direct and indirect evidence was performed to estimate risk ratios (RRs) with 95% confidence intervals (CIs). RESULTS: A total of 17 randomized controlled trials with 1760 patients were included. Beta-lactam (BL) therapy combined with a beta-lactamase inhibitor (BLI) was associated with a significant reduction in all-cause mortality compared with colistin monotherapy (RR 0.62, 95% CI 0.39-0.99; very low certainty evidence). Colistin-based combination therapies, particularly combinations of colistin with BL/BLIs, achieved higher clinical cure (RR 4.43, 95% CI 1.44-13.66; very low certainty evidence) and microbiological eradication rates (RR 9.50, 95% CI 1.34-67.27; very low certainty evidence) than colistin monotherapy. In terms of safety, BL/BLI-based regimens were associated with significantly lower risks of nephrotoxicity compared with colistin-based regimens. CONCLUSION: Beta-lactam therapy combined with a beta-lactamase inhibitor was associated with a significant reduction in all-cause mortality while colistin-based combination therapies particularly…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,760 participants or records.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.